BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17292598)

  • 1. Transcriptional regulation in early B cell development.
    Fuxa M; Skok JA
    Curr Opin Immunol; 2007 Apr; 19(2):129-36. PubMed ID: 17292598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Context-dependent regulation of hematopoietic lineage choice by HEBAlt.
    Wang D; Claus CL; Rajkumar P; Braunstein M; Moore AJ; Sigvardsson M; Anderson MK
    J Immunol; 2010 Oct; 185(7):4109-17. PubMed ID: 20826759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment.
    Holmes ML; Carotta S; Corcoran LM; Nutt SL
    Genes Dev; 2006 Apr; 20(8):933-8. PubMed ID: 16618805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Pax5 target genes in early B cell differentiation.
    Pridans C; Holmes ML; Polli M; Wettenhall JM; Dakic A; Corcoran LM; Smyth GK; Nutt SL
    J Immunol; 2008 Feb; 180(3):1719-28. PubMed ID: 18209069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pax5: the guardian of B cell identity and function.
    Cobaleda C; Schebesta A; Delogu A; Busslinger M
    Nat Immunol; 2007 May; 8(5):463-70. PubMed ID: 17440452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation.
    Carotta S; Holmes ML; Pridans C; Nutt SL
    Cell Cycle; 2006 Nov; 5(21):2452-6. PubMed ID: 17102626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis.
    Nutt SL; Eberhard D; Horcher M; Rolink AG; Busslinger M
    Int Rev Immunol; 2001 Feb; 20(1):65-82. PubMed ID: 11342298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of EBF and Pax-5 in B lineage commitment and development.
    Maier H; Hagman J
    Semin Immunol; 2002 Dec; 14(6):415-22. PubMed ID: 12457614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The regulation of the B-cell gene expression programme by Pax5.
    Holmes ML; Pridans C; Nutt SL
    Immunol Cell Biol; 2008 Jan; 86(1):47-53. PubMed ID: 17998914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foxp1 is an essential transcriptional regulator of B cell development.
    Hu H; Wang B; Borde M; Nardone J; Maika S; Allred L; Tucker PW; Rao A
    Nat Immunol; 2006 Aug; 7(8):819-26. PubMed ID: 16819554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
    Souabni A; Cobaleda C; Schebesta M; Busslinger M
    Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci.
    Beck K; Peak MM; Ota T; Nemazee D; Murre C
    J Exp Med; 2009 Sep; 206(10):2271-84. PubMed ID: 19752184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E47 is required for V(D)J recombinase activity in common lymphoid progenitors.
    Borghesi L; Aites J; Nelson S; Lefterov P; James P; Gerstein R
    J Exp Med; 2005 Dec; 202(12):1669-77. PubMed ID: 16365147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Erg-driven transcriptional program controls B cell lymphopoiesis.
    Ng AP; Coughlan HD; Hediyeh-Zadeh S; Behrens K; Johanson TM; Low MSY; Bell CC; Gilan O; Chan YC; Kueh AJ; Boudier T; Feltham R; Gabrielyan A; DiRago L; Hyland CD; Ierino H; Mifsud S; Viney E; Willson T; Dawson MA; Allan RS; Herold MJ; Rogers K; Tarlinton DM; Smyth GK; Davis MJ; Nutt SL; Alexander WS
    Nat Commun; 2020 Jun; 11(1):3013. PubMed ID: 32541654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHD4 is essential for transcriptional repression and lineage progression in B lymphopoiesis.
    Arends T; Dege C; Bortnick A; Danhorn T; Knapp JR; Jia H; Harmacek L; Fleenor CJ; Straign D; Walton K; Leach SM; Feeney AJ; Murre C; O'Connor BP; Hagman JR
    Proc Natl Acad Sci U S A; 2019 May; 116(22):10927-10936. PubMed ID: 31085655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Losing B cell identity.
    Carotta S; Nutt SL
    Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
    Tagoh H; Ingram R; Wilson N; Salvagiotto G; Warren AJ; Clarke D; Busslinger M; Bonifer C
    EMBO J; 2006 Mar; 25(5):1070-80. PubMed ID: 16482219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional regulation of B cell lineage commitment.
    Nutt SL; Kee BL
    Immunity; 2007 Jun; 26(6):715-25. PubMed ID: 17582344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.